Regulation & law · 03/10/2016
FDA Issues Correction to Announcement for Antimicrobial Resistance Diagnostic Test Challenge
The US Food and Drug Administration (FDA) has issued a correction to its announcement regarding the requirements and registration for the 'Antimicrobial Resistance Rapid, Point-of-Need Diagnostic Test' challenge, which aims to combat antimicrobial resistance.
Original source language: Federal Register — All DocumentsOpen original release →